Results 11 to 20 of about 131,333 (298)

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib

open access: yesFrontiers in Oncology, 2021
Cabozantinib (XL-184) is a multitarget tyrosine kinase inhibitor (TKI) targeting receptor tyrosine kinases (RTKs) involved in oncogenesis and angiogenesis.
Fabio Scirocchi   +7 more
doaj   +4 more sources

Immunogenic Cell Death Induction by Ionizing Radiation [PDF]

open access: yesFrontiers in Immunology, 2021
Immunogenic cell death (ICD) is a form of regulated cell death (RCD) induced by various stresses and produces antitumor immunity via damage-associated molecular patterns (DAMPs) release or exposure, mainly including high mobility group box 1 (HMGB1 ...
Mengqin Zhu   +17 more
doaj   +3 more sources

Immunogenicity of cell death driven by immune effectors [PDF]

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Whether cell death caused by T lymphocytes and natural killer (NK) cells would be immunogenic per se has been a matter of intense debate. Two back-to-back papers from the Melero’s and Pardo’s groups have now resolved this conundrum, demonstrating that T ...
Lorenzo Galluzzi   +2 more
doaj   +3 more sources

Dynamical Boolean Modeling of Immunogenic Cell Death [PDF]

open access: yesFrontiers in Physiology, 2020
As opposed to the standard tolerogenic apoptosis, immunogenic cell death (ICD) constitutes a type of cellular demise that elicits an adaptive immune response.
Andrea Checcoli   +20 more
doaj   +4 more sources

Immunogenic Cell Death in Hematological Malignancy Therapy

open access: yesAdvanced Science, 2023
Although the curative effect of hematological malignancies has been improved in recent years, relapse or drug resistance of hematological malignancies will eventually recur.
Zhaoyun Liu   +5 more
doaj   +3 more sources

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma [PDF]

open access: yesFrontiers in Cell and Developmental Biology, 2019
Over the past decades, immunotherapy has demonstrated a prominent clinical efficacy in a wide variety of human tumors. For many years, apoptosis has been considered a non-immunogenic or tolerogenic process whereas necrosis or necroptosis has long been ...
Alfonso Serrano-del Valle   +3 more
doaj   +3 more sources

eIF2α phosphorylation: A hallmark of immunogenic cell death [PDF]

open access: yesOncoImmunology, 2018
Immunogenic cell death (ICD) induced by anticancer chemotherapeutics is usually preceded by premortem stress affecting the endoplasmic reticulum (ER). This ER stress does not reflect a canonical unfolded protein response (UPR) but rather manifests solely
Lucillia Bezu   +5 more
doaj   +3 more sources

Immunogenic and tolerogenic cell death [PDF]

open access: yesNature Reviews Immunology, 2009
The immune system is routinely exposed to dead cells during normal cell turnover, injury and infection. Mechanisms must exist to discriminate between different forms of cell death to correctly eliminate pathogens and promote healing while avoiding responses to self, which can result in autoimmunity.
Green, Douglas R.   +3 more
openaire   +2 more sources

Autophagy Modulates Immunogenic Cell Death in Cancer. [PDF]

open access: yesCancers (Basel)
Immunogenic cell death (ICD) is a subtype of regulated cell death characterized by the spatiotemporally coordinated emission of damage-associated molecular patterns (DAMPs), such as calreticulin (CALR), ATP, and high-mobility group box-1 (HMGB1), which collectively prime tumor-specific T-cell responses. Autophagy, a lysosome-dependent catabolic process,
Matsushita M, Moriwaki M.
europepmc   +4 more sources

Immunogenic cell death in cancer immunotherapy

open access: yesBMB Reports, 2023
Cancer immunotherapy has been acknowledged as a new paradigm for cancer treatment, with notable therapeutic effects on certain cancer types. Despite their significant potential, clinical studies over the past decade have revealed that cancer immunotherapy has low response rates in the majority of solid tumors.
Minji Choi   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy